
11.34 Delayed Data As of Aug 05 | ![]() Today’s Change | 4.76 Today|||52-Week Range 15.25 | +58.16% Year-to-Date |
ProPhase Labs, Inc. (PRPH) Dips More Than Broader Markets: What You Should Know Aug 02 / Zacks.com - Paid Partner Content | Strength Seen in ProPhase Labs, Inc. (PRPH): Can Its 8% Jump Turn into More Strength? Jul 26 / Zacks.com - Paid Partner Content |
Previous close | 10.81 |
Today’s open | 10.87 |
Day’s range | 10.83 - 11.65 |
Volume | 148,230 |
Average volume (3 months) | 127,849 |
Market cap | $163.5M |
Earnings growth (last year) | -- |
Earnings growth (this year) | +127.50% |
Earnings growth (next 5 years) | +1.00% |
Revenue growth (last year) | +444.59% |
P/E ratio | 11.1 |
Price/Sales | 1.67 |
Price/Book | 2.79 |
Today’s change | Today’s % change | |
---|---|---|
HROWHarrow Health Inc | -0.05 | -0.75% |
PBYIPuma Biotechnology I... | +0.57 | +17.43% |
ASRTAssertio Holdings In... | -0.01 | -0.25% |
FENCFennec Pharmaceutica... | +0.25 | +3.63% |
Next reporting date | August 12, 2022 |
EPS forecast (this quarter) | $0.18 |
Annual revenue (last year) | $79.0M |
Annual profit (last year) | $6.3M |
Net profit margin | 7.94% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Garden City, New York |